Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Symptom burden of atopic dermatitis in early childhood assessed from daily monitoring of symptoms and topical steroid use

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Prevalence of asthma in patients with atopic dermatitis: A systematic review and meta-analysis

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Risk of systemic infections in adults with atopic dermatitis: A nationwide cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Maternal 17q21 genotype influences prenatal vitamin D effects on offspring asthma/recurrent wheeze

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Chemicals in moisturizers may promote type 2 inflammation and food allergy

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  3. Genetic association study of childhood aggression across raters, instruments, and age

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Long-term exposure to ambient air pollution and road traffic noise and asthma incidence in adults: The Danish Nurse cohort

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Fish Oil Supplementation in Pregnancy and Neurodevelopment in Childhood-A Randomized Clinical Trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Background: To our knowledge, disease burden of atopic dermatitis (AD) as number of days with symptoms and medical treatment has never been studied as measure of severity. Objectives: To investigate risk factors for AD burden in the first 3 years of life. Methods: The Copenhagen Prospective Studies on Asthma in Childhood 2010 included 700 children. AD burden was assessed by daily diary entries with information on AD and steroid days measuring 18 possible heritable, prenatal, and postnatal environmental exposures. Results: The children with AD had a median (interquartile range) of 136 symptom days (61-294 days) and 72 steroid days (27-145 days) during the first 3 years of life, with the highest disease burden in the second year of life. The multivariable risk factor analysis showed that maternal AD and childhood allergic sensitization were associated with a higher number of AD days and maternal AD, filaggrin mutation, and allergic sensitization were associated with a higher number of steroid days. Limitations: Participants with a personal interest in atopic diseases could be more likely to participate. Conclusion: Children's burden of AD, assessed quantitatively as AD and steroid days, demonstrated positive associations with maternal AD, filaggrin mutation, and early-life allergic sensitization, with the highest disease burden in the second year of life.

OriginalsprogEngelsk
TidsskriftJournal of the American Academy of Dermatology
Vol/bind84
Udgave nummer3
Sider (fra-til)725-734
Antal sider10
ISSN0190-9622
DOI
StatusUdgivet - mar. 2021

ID: 61273841